|
 
- 积分
- 3495
- 威望
- 3495
- 包包
- 4879
|
 
美国冷泉港和国际干细胞协会（ISSCR）联合举办的细胞编程和重编程会议（Joint CSH Asia/ISSCR Conference on Cellular Programs & Reprogramming），于2011-10-24晚到2011-10-28中午结束，共开了3天半。来自世界各地的46个演讲者，围绕以下范围：1.Human Stem Cells; 2.Control of Pluripotency; 3.Differentiation Mechanisms; 4..Cell Interactions; 5.Molecular Control; 6.Cell Lineage; 7.Cell Therapies. 进行演讲。只采取全体大会演讲的形式，没有分会场交流。全体参会人数约430人，国内参会者应在一半以上。: x M% i/ z1 C7 }) K7 @
7 \5 Y m7 Z% V" X. g
几点参会评论：% W. S5 G5 ^/ E* u
1.本次会议演讲范围较广，主要是干细胞的基础演讲，大概2个演讲者提到干细胞临床治疗，因此对临床医师受益有限。
. ?% A* H( d% h- g0 p' G2.许多国际著名干细胞领域权威给予精彩演讲，且绝大部分演讲内容未发表，但视乎没有让人感觉“耳目一新、眼前一亮”的报告。
( `# w! w2 m* D$ S7 y2 n- p% J3.国内干细胞大牛仅裴端卿、邓宏魁参会（小牛惠立建也给talk），这样的干细胞国际盛会，又是在中国举办，国内其他干细胞大牛到了哪里？为什么不参会？我非常想见到国内权威能向国际权威提几个精彩的问题，并进行辩论，但可惜没看到，只是邓宏魁、惠立建各提了一个基本的问题。国内研究生参会较多，且提问较积极，虽然问题较基本、英文发音不准，但不怯场，值得表扬。* C" _& M! U5 t0 G7 E
4.国际大佬基本上天天参会，较容易见到，也愿意回答问题，如国际皮肤干细胞的权威Elaine Fuchs教授，经常提问题，也天天被学生包围，不像国内某些大佬，一演讲完就找不到人了，像是怕见人。( d, O) F5 g `4 m' _
5.大家几乎一致认为会议组织的很好，住宿条件非常好，5星级宾馆，宾馆周围环境非常优美。会议伙食也非常好，已听到多人抱怨说吃胖了，回去要减肥。本人多次在国外参加ISSCR组织的年会，不得不说这是吃得最好的一次。会议结束前晚组织的具有苏州特色的文艺表演，让一些国外参会者看的眼都直了。" D! C# m% K) a" C; q5 d
4 F' N, v+ {/ Q7 w4 J" @
大会演讲嘉宾有：' w6 R: O8 E0 V% ?
1.Monday, October 24
' j) q( k' u; eWelcome and Overview
5 V3 U# r' W3 D5 CChairperson: Ronald D. McKay, PhD
0 D& n5 Q9 p" l' c
5 L' o. _" O: X3 mOpening Keynote: Elaine Fuchs, PhD, The Rockefeller University, USA
, e& \4 L8 s! P' X" p8 a( }, B2 @6 a" Y3 r! r3 B$ M* ?
2.Tuesday, October 25 Session I: Human Stem Cells' n& v$ S$ c8 Q8 g
Chairperson: Hongkui Deng, PhD
; k0 ?0 D, I; e, O$ o! ?% x, o+ e `. M: b5 p* ^9 U
Fred Gage, PhD, Salk Institute for Biological Studies, USA * ~1 Z& v) ~- R' e' Y# `4 Y" T* G* l
Esther Y. Son, Howard University
1 B# p) [( @! H" yGong Chen, Pensylvania state University,
" c5 L+ G' z2 t* ZWolf Reik, MD, PhD, The Babraham Institute, United Kingdom / s7 @+ g1 Z. Q* V
Linzhao Cheng, PhD, Johns Hopkins University, USA 1 X# D1 A- U3 }% c4 G, g' ^7 @$ T
Meng Li, Imperial College London
! [. n* \) @# d* I" X/ e" J+ sJoan Li, University of Gueensland; Y& F, z3 k4 D8 z! u
Richard A. Young, PhD, Whitehead Institute/M.I.T., USA
3 m/ Y5 W0 X+ i" U+ H4 A. |: o6 w3 C4 g' O5 d* W8 s
3.Session II: Control of Pluripotency' f$ {8 A0 o1 a& [2 y
Chairperson: Hongkui Deng, PhD* W# R4 B8 ^! o& F2 a) A# k4 o' b
6 s p- h' [% r7 U) E
Marius Wernig, MD, Stem Cell Institute, Stanford University, USA
7 M+ ^9 |& A6 ]Wenyu Zhou, University of Washington% s- ]5 o3 s- s* Q" g* C' \
Shuibing Chen, Weill Cornell Medical College3 f" b3 y: `0 Q$ L/ [5 `! \7 y
Jennifer Nichols, PhD, Cambridge Stem Cell Initiative, University of Cambridge, UK
5 n. f# l- G; x8 J. IYi Zhang, PhD, University of North Carolina, USA$ c! t' V) c, X6 U
Alice E. Chen, Stemgene Inc., Cambage
c: }7 T2 G0 V- MHitoshi Niwa, MD, PhD, Riken Center for Developmental Biology, Japan * b9 x# p' z& k7 B4 A
' s i! ^9 @3 ^0 V0 s4.Session III: Poster presentations with refreshments
6 X* j$ _' @: C4 M- v$ z& ]# r; k5 `
3 e5 y4 G. q3 y* P4 ^' u, `4 h5. Wednesday, October 26 Session IV: Differentiation Mechanisms , a( Y% [( v1 o
Chairperson: V. Narry Kim, DPhill5 U, n: d) j" v6 g0 _) A
4 @6 K' I4 c3 q' N2 b) P% zDuanqing Pei, PhD, Guangzhou Institute of Biomedicine and Health, China 6 e6 _2 S& h, [$ w; B
Feng Ma, CAMC,
& U' N7 K% D1 K) N9 [: [( f% e7 GEric Deneault, University of Montreal,. N2 r% ]9 s+ q, t
Hongkui Deng, PhD, Peking University, China
& c' m4 `* U8 L/ C8 P" F! `5 l& |Deepak Srivastava, MD, Gladstone Institute of Cardiovascular Disease, USA
( t: @) ^$ \) j; m6 b# X3 u+ u2 z, ELijian HUI, Shanghai,1 Z/ \* u, w# P6 m& W/ a' H$ w, `
Fiona Watt, DPhil, Cancer Research UK Cambridge Research Institute, United Kingdom9 G; q) Z' h' ?! z
+ o3 b0 h- ]3 i6 |
6.Session V: Cell Interactions / J3 G" a- }6 u3 b* i8 S2 U
Chairperson: V. Narry Kim, DPhill/ A% N3 T0 q) e* F; q
) E! ~4 P% p# z5 l( i: N1 zLinheng Li, PhD, Stowers Institute for Medical Research, USA
6 w4 w) v0 S' s E+ S% A" C0 w/ sFeng Liu, Zoology of China
8 |+ [0 L4 D9 G: z$ b0 vHiromitsu Nakauchi, MD, PhD, Institute of Medical Science, University of Tokyo, Japan- f3 V- A! Z8 n- L( y
Toshio Suda, MD, Keio University School of Medicine, Japan! _. @8 K3 h7 I, C) D* A
Guoping Fan, UCLA
. g6 K1 j) K, rHideyuki Okano, MD, PhD, Keio University School of Medicine, Japan & }$ Z: K6 _3 i
1 h1 E" _' E u, L
7. Thursday, October 276 a6 M5 c8 Y* G3 g2 P+ w+ y
Session VI: Molecular Control
+ A. A6 ^. ~0 w* c$ zChairperson: Richard A. Young, PhD/ e. n( I9 s7 L# W4 t8 c; y; G, t) a
( C* U* c1 [ \9 uJoanna Wysocka, PhD, Stanford University, USA3 M3 n7 R y" b4 e7 `' S3 [* i
Lin He, UC Berkeley
* v' f4 A! R9 Q0 _Andrew Xiao, Yale University
" Q7 E( j. d; K& NV. Narry Kim, DPhil, Seoul National University, Korea& `& ^( R( ^( B
Yukiko Gotoh, PhD, University of Tokyo, Japan- P8 U" g9 Y9 p8 U: _$ T% w
Gang Wang, CAS, China
1 I; x0 r9 D% E. _ i! ~Shengxi Guan, New England Biolab, m& _# V7 S& C: m1 z
Zhaoyu Lin, Nanjing University
: {8 I7 G N9 d# V5 oHaifan Lin, PhD, Yale University School of Medicine, USA
: @! i& S! I. Z, i) \
( J1 q! D8 D4 x; s+ o* Y( V" f0 z1 J8.Session VII: Cell Lineage C+ x; h8 ?- ]3 d
Chairperson: Richard A. Young, PhD/ q( T( }# O9 d7 G" {
4 m* m3 L! Z, r1 n4 n K! g G
Anna-Katerina Hadjantonakis, MD, Memorial Sloan-Kettering Cancer Center, USA 3 K5 E' }" u1 o! e2 \- b
Ling-Ling Chen, PhD, Shanghai Institute for Biological Sciences, China
1 m9 m n N% L+ N$ }5 WMark Krasnow, MD, PhD, Stanford University School of Medicine, USA
% {0 z- T d i6 a% [& QRicardo A. Rossello, Howard Medical School5 p7 C K1 F* R, t( V9 v! z
Sheng Ding, Gladstone Institute, UCSF. z$ @9 f# u9 B) a% ~3 Q
7 u. T4 N+ E/ H: o( J' H0 B$ S9.Friday, October 28 Closing Session: Cell Therapies
2 h0 O; ^# J- k) D, KChairperson and closing remarks: Ronald D. McKay, PhD
5 w+ _4 d/ {! v6 @9 ]
9 K7 p$ X3 a8 BLorenz Studer, MD, PhD, Memorial Sloan Kettering Cancer Center, USA2 [1 k6 R* V) y/ K
Kevin A. D'Amour, PhD, ViaCyte, Inc., USA
: B! I% Q6 C) w& t h* X6 _Tariq Enver, The Weatherall Institute of Molecular Medicine, UK 8 I/ W) e5 J+ {6 n2 { D6 W, k
6 i2 y W* O! h3 x- \ v) |+ f3 YClosing Keynote: Gordon M. Keller, PhD, McEwen Center for Regenerative Medicine Ontario Cancer Institute, Canada
+ E8 Y% u- F% R# F! e5 K A% [2 X; z# z% q
会场照片
`! q" u6 r' d+ J0 { ?0 r6 x; {; \+ v' Z# @+ X3 Q
7 |+ u+ A7 y0 Z3 W1 W2 R
|
-
总评分: 威望 + 110
包包 + 220
查看全部评分
|
发表于 2011-10-31 20:02
发表于 2011-11-1 01:03
